Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health

You can search in the form below for information related to drugs including Subsidy percentage

Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022

...

195

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M05BX04	XGEVA	BioTech	Denosumab - 120mg	120mg	Injectable solution	33,545,669 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 45mg	45mg	Injectable solution	L.L
A10AD06	RYZODEG	BioTech	Insulin degludec - 70%, Insulin aspart - 30%	100IU/ml	Injectable solution	7,058,661 L.L
M05BX06	EVENITY	BioTech	Romosozumab - 105mg/1.17ml	105mg/1.17ml	Injectable solution	56,729,091 L.L
A10AE01	HUMULIN N U-100	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable suspension	701,486 L.L
A10AE01	INSULATARD	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable suspension	752,552 L.L
A10AE01	INSULATARD	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable suspension	752,552 L.L
A10AE01	JUSLINE N	BioTech	Insulin human isophane - 100IU/ml	100IU/ml	Injectable suspension	401,809 L.L
S01LA04	LUCENTIS	BioTech	Ranibizumab - 10mg/ml	10mg/ml	Injectable solution	51,255,093 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 300mg	300mg	Injectable solution	L.L
A10AE04	BASAGLAR KWIKPEN	BioTech	Insulin glargine - 100U/ml	100U/ml	Injectable solution	4,114,846 L.L
S01LA05	EYLEA	BioTech	Aflibercept - 40mg/ml	40mg/ml	Injectable solution	65,161,855 L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 400mg/20ml	400mg/20ml	Injectable concentrate for solution	L.L
A10AE04	GLARTUS	BioTech	Insulin glargine - 100U/ml	100U/ml	Injectable solution	1,346,530 L.L
S01LA05	EYLEA	BioTech	Aflibercept - 8mg/0.07ml	114.3mg/ml	Injectable solution	78,332,038 L.L
L04AA23	TYSABRI	BioTech	Natalizumab - 300mg/15ml	300mg/15ml	Injectable concentrated solution	L.L
A10AE04	LANTUS SOLOSTAR	BioTech	Insulin glargine - 100IU/ml	100IU/ml	Injectable solution	4,992,375 L.L
S01LA06	BEOVU	BioTech	Brolucizumab - 120mg/ml	120mg/ml	Injectable solution	42,752,178 L.L
A10AE04	LANTUS	BioTech	Insulin glargine - 100IU/ml	100IU/ml	Injectable solution	3,327,354 L.L
J06BD01	SYNAGIS	BioTech	Palivizumab - 100mg/ml	100mg/ml	Injectable solution	57,429,464 L.L
A10AE04	TOUJEO	BioTech	Insulin glargine - 300Units/ml	300Units/ml	Injectable solution	4,559,658 L.L
J06BD01	SYNAGIS	BioTech	Palivizumab - 50mg/0.5ml	50mg/0.5ml	Injectable solution	38,316,693 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 80mg/4ml	80mg/4ml	Injectable concentrated solution	L.L
A10AE06	TRESIBA	BioTech	Insulin degludec - 100IU/ml	100IU/ml	Injectable solution	6,223,335 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 162mg/0.9ml	162mg/0.9ml	Injectable solution	L.L
A10AE54	SULIQUA	BioTech	Insulin glargine - 100IU/ml, Lixisenatide - 50mcg/ml		Injectable solution	11,286,573 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 200mg/10ml	200mg/10ml	Injectable concentrated solution	L.L
A10AE54	SULIQUA	BioTech	Insulin glargine - 100IU/ml, Lixisenatide - 33mcg/ml		Injectable solution	7,975,793 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 400mg/20ml	400mg/20ml	Injectable concentrated solution	L.L
A10AE56	XULTOPHY	BioTech	Insulin degludec - 100U/ml, Liraglutide - 3.6mg/ml		Injectable solution	13,503,847 L.L

...

195